HBV Mutation Detail Information

> M204I Search Result


Mutation Information
Mutation Site M204I
Mutation Type Amino acid level
Gene/Protein/Region Type RT
Genotype/Subtype A;D
Relevant Drug tenofovir (TDF)
Country South Africa
Literature Information
PubMed PMID 32663786
Disease Chronic hepatitis B
Published Year 2020
Journal Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
Title Evidence of tenofovir resistance in chronic hepatitis B virus (HBV) infection: An observational case series of South African adults.
Author Mokaya J,Maponga TG,McNaughton AL,Van Schalkwyk M,Hugo S,Singer JB,Sreenu VB,Bonsall D,de Cesare M,Andersson M,Gabriel S,Taljaard J,Barnes E,Preiser W,Van Rensburg C,Matthews PC
Evidence M204I/V and L180M are best recognised in association with 3TC resistance, but they may also be part of a combination of polymorphisms that underpins TDF resistance as there was no sustained viral suppression.

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation